- News
Full funding of VMX-C001 Phase 3 trial, late-stage product development, manufacturing and pre-launch activities VarmX shareholders to receive initial $117m...
- News
Designation recognises potential of VMX-C001 to address an unmet need in the restoration of coagulation to enable hemostasis in patients...